ES2076378T5 - Metodo para la inhibicion del desarrollo de celulas de tallo. - Google Patents

Metodo para la inhibicion del desarrollo de celulas de tallo.

Info

Publication number
ES2076378T5
ES2076378T5 ES90916178T ES90916178T ES2076378T5 ES 2076378 T5 ES2076378 T5 ES 2076378T5 ES 90916178 T ES90916178 T ES 90916178T ES 90916178 T ES90916178 T ES 90916178T ES 2076378 T5 ES2076378 T5 ES 2076378T5
Authority
ES
Spain
Prior art keywords
stem cells
inhibition
development
agents
cycling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90916178T
Other languages
English (en)
Other versions
ES2076378T3 (es
Inventor
Ian B Pragnell
Debra D Donaldson
Gerald J Graham
Gordon G Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRC Technology Ltd
Genetics Institute LLC
Original Assignee
CRC Technology Ltd
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27021719&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2076378(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by CRC Technology Ltd, Genetics Institute LLC filed Critical CRC Technology Ltd
Publication of ES2076378T3 publication Critical patent/ES2076378T3/es
Application granted granted Critical
Publication of ES2076378T5 publication Critical patent/ES2076378T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCION PRESENTA UN METODO PARA PROTEGER EL CICLO O DIVISION DE CELULAS VEGETALES DE LOS EFECTOS CITOTOXICOS DE AGENTES QUIMIOTERAPEUTICOS Y DE LA RADIACION A BASE DE ADMINISTRAR, ANTES DE LA EXPOSICION A ESTOS AGENTES, UNA CANTIDAD EFECTIVA DE UN FACTOR INHIBIDOR DE CELULAS VEGETALES ASI COMO UNA COMPOSICION UTIL PARA ELLO.
ES90916178T 1989-09-25 1990-09-25 Metodo para la inhibicion del desarrollo de celulas de tallo. Expired - Lifetime ES2076378T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41230389A 1989-09-25 1989-09-25
US58171390A 1990-09-13 1990-09-13

Publications (2)

Publication Number Publication Date
ES2076378T3 ES2076378T3 (es) 1995-11-01
ES2076378T5 true ES2076378T5 (es) 1999-10-16

Family

ID=27021719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90916178T Expired - Lifetime ES2076378T5 (es) 1989-09-25 1990-09-25 Metodo para la inhibicion del desarrollo de celulas de tallo.

Country Status (10)

Country Link
US (1) US5674841A (es)
EP (1) EP0494268B2 (es)
JP (1) JPH05502443A (es)
AT (1) ATE124421T1 (es)
CA (1) CA2064558C (es)
DE (1) DE69020573T3 (es)
DK (1) DK0494268T4 (es)
ES (1) ES2076378T5 (es)
MX (1) MX9203438A (es)
WO (1) WO1991004274A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE177472T1 (de) * 1990-09-14 1999-03-15 Chiron Corp Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
NZ246354A (en) * 1991-12-23 1995-10-26 British Bio Technology Stem cell inhibiting proteins and their production and use
FR2691153B1 (fr) * 1992-05-18 1995-06-30 Serbio Dodecapeptides monomere et dimere, utilisation en tant qu'agents anti-megacaryocytaires.
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
PT691988E (pt) * 1993-03-31 2003-02-28 Wellstat Therapeutics Corp Inibidor da proliferacao de celulas estaminais e suas utilizacoes
US6610654B2 (en) 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
GB9308060D0 (en) * 1993-04-19 1993-06-02 Cancer Res Campaign Tech Stem cell inhibitor
ES2172536T3 (es) * 1993-06-15 2002-10-01 British Biotech Pharm Liberacion y movilizacion de celulas hematopoyeticas.
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6451562B1 (en) 1993-12-22 2002-09-17 Human Genome Sciences, Inc. Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
EP0696639B1 (en) * 1994-08-13 2002-04-17 Boehringer Mannheim Gmbh Use of interferon gamma for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells
DE69526395D1 (de) * 1994-08-13 2002-05-23 Roche Diagnostics Gmbh Verwendung von Interferon-gamma zur Vermeidung der Proliferation und Differenzierung der primitiven Hämapoietischen Vorläuferzellen
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US5981230A (en) * 1994-08-23 1999-11-09 Human Genome Sciences, Inc. Polynucleotide encoding chemokine β-4
US6139832A (en) 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
US6040431A (en) 1995-06-07 2000-03-21 Stryker Corporation Single chain analogs of the TGF-β superfamily (morphons)
ZA97990B (en) * 1996-02-09 1997-08-06 Schering Corp Mammalian dendritic cell chemokine reagents.
US6410268B1 (en) 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
US5910431A (en) * 1996-03-19 1999-06-08 Human Genome Sciences, Inc. Polynucleotides encoding chemokine α-2
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
CA2245224A1 (en) 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
CA2305787A1 (en) 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
ATE258444T1 (de) 1998-03-13 2004-02-15 Univ British Columbia Therapeutische chemokine rezeptor antagonisten
ATE363293T1 (de) * 1999-03-30 2007-06-15 Ran Kornowski Injektion von autologem knochenmark in den herzmuskel
US7097832B1 (en) 1999-03-30 2006-08-29 Myocardial Therapeutics, Inc. Intramyocardial injection of autologous bone marrow
US7368425B2 (en) 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
CA2335109A1 (en) * 2000-04-12 2001-10-12 Chemokine Therapeutics Corporation Cxcr4 agonist treatment of hematopoietic cells
US7378098B2 (en) 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
US20050059584A1 (en) 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム　リサーチ　ディベロップメント　カンパニー 胚性細胞の定方向分化
AU2003225237A1 (en) 2002-05-01 2003-11-17 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US8921315B1 (en) * 2008-04-24 2014-12-30 Neumedicines, Inc. Method of increasing survival of a human subject having exposure to an acute exposure to non-therapeutic whole body ionization by administering a therapeutically effective dose of IL-12
SG10201509499RA (en) 2010-11-19 2015-12-30 Eisai R&D Man Co Ltd Neutralizing anti-ccl20 antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822776A (en) * 1981-09-08 1989-04-18 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
EP0310316B1 (en) * 1987-09-28 1995-02-01 Beecham Inc. TGEV-virus of swine as a dog vaccine
US5041289A (en) * 1987-11-13 1991-08-20 Becton Dickinson And Company Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells
WO1990002762A1 (en) * 1988-09-02 1990-03-22 The Rockefeller University Macrophage-derived inflammatory mediator (mip-2)
AU5958090A (en) * 1989-06-29 1991-01-17 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method for protecting bone marrow against chemotherapeutic drugs and radiation therapy using transforming growth factor beta 1

Also Published As

Publication number Publication date
DK0494268T4 (da) 1999-11-08
US5674841A (en) 1997-10-07
DK0494268T3 (da) 1995-08-28
ATE124421T1 (de) 1995-07-15
EP0494268B1 (en) 1995-06-28
DE69020573T3 (de) 1999-12-16
ES2076378T3 (es) 1995-11-01
CA2064558C (en) 2001-01-30
DE69020573T2 (de) 1995-11-30
WO1991004274A1 (en) 1991-04-04
MX9203438A (es) 1992-07-01
DE69020573D1 (de) 1995-08-03
EP0494268B2 (en) 1999-04-28
CA2064558A1 (en) 1991-03-26
EP0494268A1 (en) 1992-07-15
JPH05502443A (ja) 1993-04-28

Similar Documents

Publication Publication Date Title
ES2076378T5 (es) Metodo para la inhibicion del desarrollo de celulas de tallo.
IT1164634B (it) Derivati cefalosporinici e composizioni antibatteriche che li contengono,nonche' procedimento per la loro produzione
ES472641A1 (es) Procedimiento para la obtencion de propenil-aminas
JPS5249258A (en) Polyolefin compositions
IT8049060A0 (it) Procedimento per la polimerizzazio ne per irradiazione di composizioni di poliacrilati
IT8422785A0 (it) Derivati del benzossazolone e delbenzotiazolone, procedimenti per la loro preparazione e composizione farmaceutica che li contiene.
ES275579Y (es) Juego de celdas para el crecimiento de plantas
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
DK266883A (da) Middel til afbladning af planter med synergistisk virkning
IT8424283A0 (it) Uso di derivati del tiofene nel trattamento dei tumori, composizioni farmaceutiche che licontengono e composti atti allo scopo.
BR8108410A (pt) Composicao para o condicionamento de plantas,contendo titanio
JPS5271253A (en) Compound lens of high resolving power
ES477562A1 (es) Procedimiento para preparar derivados de alcanolamina.
ES471809A1 (es) Procedimiento para preparar derivados de naftaleno
IT8522359A0 (it) Composizioni farmaceutiche che li derivati di vitamina d,contengono e loro precursori.
MXPA99009874A (es) Nuevos derivados de amidina.
FR2454803A1 (fr) Composition amincissante et procede d'utilisation de celle-ci
IT8320920A0 (it) Derivati di cicloalcani, procedimento per la loro preparazione e composizioni che licontengono.
IT8522868A0 (it) Derivati tienopiridinici, procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
FR2392966A1 (fr) Nouveaux acides uree-bis(naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique
ES8608493A1 (es) Procedimiento de obtencion de nuevos derivados nitrogenados,penta o hexaciclicos sustituidos por un radical aminado.
IT8023631A0 (it) Derivati di nitroalcanol,procedimento per produrli e composizioni di protezione per piante che li contengono.
JPS5378248A (en) Method of preventing yellowing of polyolefin composition
BR7808242A (pt) Composto,processo para regulacao do crescimento de plantas leguminosas,e composicao reguladora do crescimento de plantas
IT7822120A0 (it) Derivati della 1, 2,3-tiadiazolin-2-ide, procedimento per la preparazione di questi composti nonche' mezzi che licontengono con azione regolatrice della crescita per piante.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 494268

Country of ref document: ES